LEADER 01841nam  2200373Ia 450 
001 9910698901103321
005 20090430151133.0
035   $a(CKB)5470000002396850
035   $a(OCoLC)319711616
035   $a(EXLCZ)995470000002396850
100   $a20090430d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aQ4B, annex 3, evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particles$b[electronic resource] /$fInternational Conference on Harrmonisation of Technical Requrements for Registration of Pharmaceuticals for Human Use
210  1$a[Rockville, MD] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research],$d[2007]
215   $a7 unnumbered pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on Apr. 30, 2009).
300   $a"Draft consensus guideline".
300   $a"Current step 2 version, dated November 1, 2007".
320   $aIncludes bibliographical references: (page [4]).
517 3 $aEvaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particles
606   $aDrugs$xMicrobiology$xTesting
615  0$aDrugs$xMicrobiology$xTesting.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698901103321
996   $aQ4B, annex 3, evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particles$93191535
997   $aUNINA